Category: Pharmacology & Therapeutics
Keywords: dexmedetomidine, alcohol, ethanol, withdrawal (PubMed Search)
Posted: 4/28/2014 by Bryan Hayes, PharmD
Click here to contact Bryan Hayes, PharmD
Four small case series (one prospective, 3 retrospective) have concluded that dexmedetomidine (Precedex) may be a useful adjunct therapy to benzodiazepines for ethanol withdrawal in the ED or ICU. They are summarized on the Academic Life in EM blog.
A new randomized, double-blind trial evaluated 24 ICU patients with severe ethanol withdrawal.
Group 1: Lorazepam + placebo
Group 2: Lorazepam + dexmedetomidine (doses of 0.4 mcg/kg/hr and 1.2 mcg/kg/hr).
Mueller SW, et al. A randomized, double-blind, placebo-controlled, dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med 2014;42(5):1131-9. [PMID 24351375]
Follow me on Twitter (@PharmERToxGuy) and Google Plus (+bryanhayes13)
Download the UMEM Pearls App!
Subscribe to daily UMEM Pearls (FREE!) via: